Losectil 40 mg/vial (IV Injection)

40 mg vial: ৳ 90.00

Medicine Details

Indications

  • Treatment of gastric and duodenal ulcer
  • NSAID-associated duodenal and gastric ulcer treatment
  • Prophylaxis in patients with a history of NSAID-associated duodenal and gastric ulcer
  • Gastro-esophageal reflux disease treatment
  • Long-term management of acid reflux disease
  • Acid-related dyspepsia treatment
  • Severe ulcerating reflux esophagitis treatment
  • Prophylaxis of acid aspiration during general anesthesia
  • Zollinger-Ellison syndrome treatment
  • Helicobacter pylori-induced peptic ulcer treatment

Pharmacology

  • Inhibitor of gastric acid secretion
  • Blocks hydrogen-potassium-adenosine triphosphatase enzyme system
  • Onset of antisecretory effect within one hour
  • Maximum effect within two hours
  • Inhibition of secretion lasts up to 72 hours
  • Gradual return of secretory activity after discontinuation

Dosage

  • Oral dosage for various conditions
  • IV injection dosage for prophylaxis of acid aspiration
  • IV injection dosage for duodenal ulcer, gastric ulcer, or reflux esophagitis

Administration

  • Instructions for IV injection use
  • Instructions for IV infusion use

Interaction

  • Decreased intragastric acidity affecting drug absorption
  • Metabolism through cytochrome P450
  • Effect on the absorption and elimination of other drugs

Contraindications

  • Known hypersensitivity to Omeprazole
  • Need to exclude possibility of malignancy before treatment

Side Effects

  • Mild and reversible adverse reactions
  • Skin rash, urticaria, and pruritus
  • Photosensitivity, bullous eruption, erythema multiforme
  • Diarrhoea, headache, constipation, nausea/vomiting
  • Dry mouth, stomatitis, candidiasis
  • Dizziness, somnolence, reversible mental confusion
  • Arthritic and myalgic symptoms
  • Blurred vision, taste disturbance, peripheral oedema
  • Gynaecomastia, increases in liver enzymes

Pregnancy & Lactation

  • No adverse effects of Omeprazole on pregnancy or fetus/child
  • Use during pregnancy considered safe
  • No information available on passage into breast milk or effects on neonate
  • Discontinuation of breastfeeding if essential

Precautions & Warnings

  • Avoid concomitant use with clopidogrel
  • Possible association with increased risk for osteoporosis-related fractures
  • Atrophic gastritis noted in long-term users
  • Potential for methotrexate toxicities with concomitant use

Therapeutic Class

  • Proton Pump Inhibitor

Storage Conditions

  • Keep in a dry place away from light and heat
  • Keep out of the reach of children

Related Brands